A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis
Objective: To prepare a novel nanoemulsion- Carbopol® 934 gel for Eugenol, in order to prevent the periodontitis. Material and methods: Spontaneous emulsification method was used for the preparation of nanoemulsion in which it contain Eugenol (oil phase), Tween-80 (surfactant), and PEG (co-surfactan...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-09-01
|
Series: | Saudi Pharmaceutical Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016419300702 |
id |
doaj-8e4de1b66652485295f79d2d8bb5a3e5 |
---|---|
record_format |
Article |
spelling |
doaj-8e4de1b66652485295f79d2d8bb5a3e52020-11-25T02:13:09ZengElsevierSaudi Pharmaceutical Journal1319-01642019-09-01276778790A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitisNiyaz Ahmad0Farhan Jalees Ahmad1Sumit Bedi2Sonali Sharma3Sadiq Umar4Mohammad Azam Ansari5Department of Pharmaceutics, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi Arabia; Department of Pharmaceutical Chemistry, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi Arabia; Corresponding author at: Department of Pharmaceutics, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.Nanomedicine Lab, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, IndiaDivision of Pediatric Dentistry, Department of Preventive Dental Sciences, College of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi ArabiaDepartment of Biomedical Dental Sciences, College of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi ArabiaDivision of Rheumatology, Department of Medicine, University of Illinois, Chicago, IL, USADepartment of Epidemic Disease Research, Institutes of Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi ArabiaObjective: To prepare a novel nanoemulsion- Carbopol® 934 gel for Eugenol, in order to prevent the periodontitis. Material and methods: Spontaneous emulsification method was used for the preparation of nanoemulsion in which it contain Eugenol (oil phase), Tween-80 (surfactant), and PEG (co-surfactant). To the development of best nanoemulsion, three-factor three-level central composite design was used in which %oil; %Smix and % water were optimized as independent variables. An optimized–nanoemulsion were converted to nanoemulsion–Carbopol® 934 gel. Results: 5.5% oil, 35.5% Smix and 59.0% water were optimized as independent and dependent variables. Finally dependent variables optimized as a particle size (nm), PDI and %transmittance were observed 79.92 ± 6.33 nm, 0.229 ± 0.019, and 98.88 ± 1.31% respectively. The values of final results for dependent variables like particle size (nm), PDI and % transmittance were evaluated as 79.92 ± 6.33 nm, 0.229 ± 0.019, and 98.88 ± 1.31%, respectively. TEM and SEM showed a spherical shape of developed nanoemulsion with refractive index (1.63 ± 0.038), zeta potential (−19.16 ± 0.11), pH (7.4 ± 0.06), viscosity (34.28 ± 6 cp), and drug content of 98.8 ± 0.09%. After that a final optimized EUG–NE–Gel was assessed on the basis of their pH measurement, drug content, syringeability, and mucoadhesion on the goat buccal mucosa. Optimized EUG-NE-Gel (Tween-80 and Carbopol® 934 used) showed the results, to improve the periodontal drug delivery of EUG in future. Conclusion: EUG-NE-Gel showed a significant role in anti-inflammatory activity, analgesic, and anesthetic, antibacterial, and treatment of periodontal disease. Keywords: Eugenol, Nanoemulsion–gel, Mucoadhesion, Anti-inflammatory & periodontal diseasehttp://www.sciencedirect.com/science/article/pii/S1319016419300702 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Niyaz Ahmad Farhan Jalees Ahmad Sumit Bedi Sonali Sharma Sadiq Umar Mohammad Azam Ansari |
spellingShingle |
Niyaz Ahmad Farhan Jalees Ahmad Sumit Bedi Sonali Sharma Sadiq Umar Mohammad Azam Ansari A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis Saudi Pharmaceutical Journal |
author_facet |
Niyaz Ahmad Farhan Jalees Ahmad Sumit Bedi Sonali Sharma Sadiq Umar Mohammad Azam Ansari |
author_sort |
Niyaz Ahmad |
title |
A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis |
title_short |
A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis |
title_full |
A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis |
title_fullStr |
A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis |
title_full_unstemmed |
A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis |
title_sort |
novel nanoformulation development of eugenol and their treatment in inflammation and periodontitis |
publisher |
Elsevier |
series |
Saudi Pharmaceutical Journal |
issn |
1319-0164 |
publishDate |
2019-09-01 |
description |
Objective: To prepare a novel nanoemulsion- Carbopol® 934 gel for Eugenol, in order to prevent the periodontitis. Material and methods: Spontaneous emulsification method was used for the preparation of nanoemulsion in which it contain Eugenol (oil phase), Tween-80 (surfactant), and PEG (co-surfactant). To the development of best nanoemulsion, three-factor three-level central composite design was used in which %oil; %Smix and % water were optimized as independent variables. An optimized–nanoemulsion were converted to nanoemulsion–Carbopol® 934 gel. Results: 5.5% oil, 35.5% Smix and 59.0% water were optimized as independent and dependent variables. Finally dependent variables optimized as a particle size (nm), PDI and %transmittance were observed 79.92 ± 6.33 nm, 0.229 ± 0.019, and 98.88 ± 1.31% respectively. The values of final results for dependent variables like particle size (nm), PDI and % transmittance were evaluated as 79.92 ± 6.33 nm, 0.229 ± 0.019, and 98.88 ± 1.31%, respectively. TEM and SEM showed a spherical shape of developed nanoemulsion with refractive index (1.63 ± 0.038), zeta potential (−19.16 ± 0.11), pH (7.4 ± 0.06), viscosity (34.28 ± 6 cp), and drug content of 98.8 ± 0.09%. After that a final optimized EUG–NE–Gel was assessed on the basis of their pH measurement, drug content, syringeability, and mucoadhesion on the goat buccal mucosa. Optimized EUG-NE-Gel (Tween-80 and Carbopol® 934 used) showed the results, to improve the periodontal drug delivery of EUG in future. Conclusion: EUG-NE-Gel showed a significant role in anti-inflammatory activity, analgesic, and anesthetic, antibacterial, and treatment of periodontal disease. Keywords: Eugenol, Nanoemulsion–gel, Mucoadhesion, Anti-inflammatory & periodontal disease |
url |
http://www.sciencedirect.com/science/article/pii/S1319016419300702 |
work_keys_str_mv |
AT niyazahmad anovelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis AT farhanjaleesahmad anovelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis AT sumitbedi anovelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis AT sonalisharma anovelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis AT sadiqumar anovelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis AT mohammadazamansari anovelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis AT niyazahmad novelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis AT farhanjaleesahmad novelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis AT sumitbedi novelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis AT sonalisharma novelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis AT sadiqumar novelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis AT mohammadazamansari novelnanoformulationdevelopmentofeugenolandtheirtreatmentininflammationandperiodontitis |
_version_ |
1724905973836939264 |